Title : Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients.

Pub. Date : 2002 Feb

PMID : 11880864






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients. Levodopa prolactin Homo sapiens
2 OBJECTIVES: The secretion of prolactin (PRL), which is a growth factor for prostate cancer cell proliferation, has been proven to present profound alterations in advanced prostate cancer patients, consisting of abnormally elevated baseline levels and paradoxical response to L-dopa. Levodopa prolactin Homo sapiens
3 OBJECTIVES: The secretion of prolactin (PRL), which is a growth factor for prostate cancer cell proliferation, has been proven to present profound alterations in advanced prostate cancer patients, consisting of abnormally elevated baseline levels and paradoxical response to L-dopa. Levodopa prolactin Homo sapiens
4 Moreover, bicalutamide therapy significantly reduced PRL increase in response to L-dopa. Levodopa prolactin Homo sapiens